A comprehensive view of Cedars-Sinai. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Cell therapy developed at Cedars-Sinai delays disease progression in Duchenne muscular dystrophy patients who have few treatment options; treatment uses cardiosphere heart muscle cells to improve heart, skeletal muscle function, blunt inflammation

Nearly 75% of people prefer annual fecal immunochemical tests over colonoscopy every 10 years for colorectal cancer screening; educating people about testing options may persuade more people to get screenings: Cedars-Sinai

COVID-19 vaccination appears to strengthened T-cell immune response in inflammatory bowel disease patients taking anti-tumor necrosis factor drug therapy; association reported between biologic drugs, reduced hospitalizations, deaths from COVID-19: study

CDC reports 80% of babies hospitalized with COVID-19 are born to unvaccinated women, while nearly 60% of newborns from vaccinated mothers protected from illness; 62% of pregnant women in US have received at least one dose of vaccine: Cedars-Sinai

Cedars-Sinai develops potential COVID-19 biological therapy using reengineered human skin cells; dermal fibroblasts called ASTEX inhibit viral replication in human lung cells, protect infected cells, repair heart, lung, muscle tissue in laboratory mice

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count